Baird Maintains Neutral on Bio-Techne, Raises Price Target to $73
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Neutral and raises the price target from $49 to $73.
Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Neutral and raises the price target from $49 to $73.